Multicore myopathy--a case report.

por Myong, N. H., Kang, Y. K., Chi, J. G., Suk, S. I.
Publicado 1993

Granulocytic sarcoma of the breast preceding acute myelogenous leukemia: a case report.

por Joo, M., Lee, H. K., Kang, Y. K., Kim, J. H.
Publicado 2000

Mesenchymal chondrosarcoma of the hyoid bone: a case report.

por Joo, M., Kang, Y. K., Kim, H. S., Lee, H. K., Park, Y. K.
Publicado 1998

Adult T-cell leukemia/lymphoma in a Korean--a case report.

por Lee, S. S., Hong, S. I., Lee, D. S., Kang, Y. K., Kim, C. W., Jang, J. J.
Publicado 1994

Primary malignant lymphomas of the stomach. Pathological and clinical analyses of 38 resected cases.

por Kang, Y. K., Kim, C. W., Kim, W. H., Jang, J. J., Park, S. H., Kim, Y. I.
Publicado 1996

A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cance...

por Kang, Y-K, Rha, S Y, Tassone, P, Barriuso, J, Yu, R, Szado, T, Garg, A, Bang, Y-J
Publicado 2014

Intrapulmonary and gastric teratoma : report of two cases.

por Joo, M., Kang, Y. K., Lee, H. K., Lee, H. S., Yum, H. K., Bang, S. W., Cho, H. J.
Publicado 1999

Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma

por Catenacci, D.V.T., Chung, H.C., Shen, L., Moehler, M., Yoon, H.H., Rosales, M.K., Kang, Y.-K.
Publicado 2021

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

por Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H-J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Publicado 2008

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

por Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Publicado 2005

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

por Yoon, D H, Ryu, M-H, Park, Y S, Lee, H J, Lee, C, Ryoo, B-Y, Lee, J-L, Chang, H-M, Kim, T W, Kang, Y-K
Publicado 2012

Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer

por Jo, J-C, Lee, J-L, Ryu, M-H, Chang, H M, Kim, M, Lee, H J, Kim, H-S, Shin, J-G, Kim, T-W, Kang, Y-K
Publicado 2012

Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib

por Kang, Y-K, Yoo, C, Ryoo, B-Y, Lee, J J, Tan, E, Park, I, Park, J H, Choi, Y J, Jo, J, Ryu, J-S, Ryu, M-H
Publicado 2013

Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer.

por Lee, J. H., Lee, J. H., Kim, T. W., Lee, K. H., Kang, Y. K., Lee, J. S., Kim, S. H., Kim, H. C., Yu, C. S., Kim, J. C., Kim, W. K.
Publicado 2001

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical...

por Kim, K-p, Jang, G, Hong, Y S, Lim, H-S, Bae, K-s, Kim, H-S, Lee, S S, Shin, J-G, Lee, J-L, Ryu, M-H, Chang, H-M, Kang, Y-K, Kim, T W
Publicado 2011

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroeso...

por Boku, N, Ryu, M -H, Kato, K, Chung, H C, Minashi, K, Lee, K -W, Cho, H, Kang, W K, Komatsu, Y, Tsuda, M, Yamaguchi, K, Hara, H, Fumita, S, Azuma, M, Chen, L -T, Kang, Y -K
Publicado 2019

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

por Lee, J-L, Kang, Y-K, Kang, H J, Lee, K-H, Zang, D Y, Ryoo, B-Y, Kim, J G, Park, S R, Kang, W K, Shin, D B, Ryu, M-H, Chang, H M, Kim, T-W, Baek, J H, Min, Y J
Publicado 2008

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2...

por Kang, Y-K, Chang, H-M, Yook, J H, Ryu, M-H, Park, I, Min, Y J, Zang, D Y, Kim, G Y, Yang, D H, Jang, S J, Park, Y S, Lee, J-L, Kim, T W, Oh, S T, Park, B K, Jung, H-Y, Kim, B S
Publicado 2013

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

por Catenacci, D.V.T., Kang, Y.-K., Yoon, H.H., Shim, B.Y., Kim, S.T., Oh, D.-Y., Spira, A.I., Ulahannan, S.V., Avery, E.J., Boland, P.M., Chao, J., Chung, H.C., Gardner, F., Klempner, S.J., Lee, K.-W., Oh, S.C., Peguero, J., Sonbol, M.B., Shen, L., Moehler, M., Sun, J., Li, D., Rosales, M.K., Park, H.
Publicado 2022

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

por Demetri, G. D., Antonescu, C. R., Bjerkehagen, B., Bovée, J. V. M. G., Boye, K., Chacón, M., Dei Tos, A. P., Desai, J., Fletcher, J. A., Gelderblom, H., George, S., Gronchi, A., Haas, R. L., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Judson, I., Kang, Y.-K., Kawai, A., Lazar, A. J., Cesne, A. Le, Maestro, R., Maki, R. G., Martín, J., Patel, S., Penault-Llorca, F., Raut, C. Premanand, Rutkowski, P., Safwat, A., Sbaraglia, M., Schaefer, I.-M., Shen, L., Serrano, C., Schöffski, P., Stacchiotti, S., Hall, K. Sundby, Tap, W. D., Thomas, D. M., Trent, J., Valverde, C., van der Graaf, W. T. A., von Mehren, M., Wagner, A., Wardelmann, E., Naito, Y., Zalcberg, J., Blay, J.-Y.
Publicado 2020